| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |